Allergan and tribe hit back at Mylan claims in SCOTUS brief

Allergan and the Saint Regis Mohawk Tribe have again urged the US Supreme Court to hear their closely-followed litigation on tribal sovereign immunity, following a submission from generic maker Mylan in the case.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

English High Court invalidates Allergan glaucoma patent

7 May 2019 One of Allergan’s patents has been invalidated after it was challenged by UK-based pharmaceutical companies Accord Healthcare and Aspire Pharma.

Americas

SCOTUS refuses to hear tribal immunity suit

16 April 2019 The US Supreme Court has declined to hear a closely-watched case on tribal immunity involving pharmaceutical company Allergan and the Saint Regis Mohawk Tribe, a Native American tribe.

Americas

Allergan and tribe ask for stay pending SCOTUS appeal

29 October 2018 Allergan and the Saint Regis Mohawk Tribe have urged the US Court of Appeals for the Federal Circuit to stay its ruling against them pending an appeal to the US Supreme Court.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Allergan and tribe hit back at Mylan claims in SCOTUS brief

More on this story

Editor's picks

Editor's picks

More features